Mitogenic and metabolic effects of type IIGF receptor overexpression in insulin receptor-deficient hepatocytes

被引:13
作者
Kim, JJ
Park, BC
Kido, Y
Accili, D
机构
[1] Columbia Univ Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
关键词
D O I
10.1210/en.142.8.3354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously shown that hepatocytes lacking insulin receptors (Ir-/-) fail to mediate metabolic responses, such as stimulation of glycogen synthesis, while retaining the ability to proliferate in response to IGFs. In this study we have asked whether overexpression. of type I IGF receptors would rescue the metabolic response of Ir-/- hepatocytes. After IGF-I stimulation, insulin receptor substrate-1 and -2 phosphorylation and PI3K activity were restored to levels similar to or greater than those seen in wild-type cells. Rates of cell proliferation in response to IGF-I increased approximately 2-fold, whereas glycogen synthesis was restored to wild-type levels, but was comparatively smaller than that elicited by overexpression of insulin receptors. In summary, overexpression of IGF-I receptors in Ir-/- hepatocytes normalized insulin receptor substrate-2 phosphorylation and glycogen synthesis to wild-type levels, whereas it increased cell proliferation above wild-type levels. Moreover, stimulation of glycogen synthesis was submaximal compared with the effect of insulin receptor overexpression. We conclude that IGF-I receptors are more efficiently coupled to cell proliferation than insulin receptors, but are less potent than insulin receptors in stimulating glycogen synthesis. The data are consistent with the possibility that there exist intrinsic signaling differences between insulin and IGF-I receptors.
引用
收藏
页码:3354 / 3360
页数:7
相关论文
共 51 条
[1]   Early neonatal death in mice homozygous for a null allele of the insulin receptor gene [J].
Accili, D ;
Drago, J ;
Lee, EJ ;
Johnson, MD ;
Cool, MH ;
Salvatore, P ;
Asico, LD ;
Jose, PA ;
Taylor, SI ;
Westphal, H .
NATURE GENETICS, 1996, 12 (01) :106-109
[2]  
Accili D, 1999, J PEDIATR ENDOCR MET, V12, P475
[3]   INSULIN-LIKE GROWTH-FACTOR-I STIMULATES TYROSINE PHOSPHORYLATION OF ENDOGENOUS C-CRK [J].
BEITNERJOHNSON, D ;
LEROITH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) :5187-5190
[4]  
CHOU JY, 2000, GENETIC MANIPULATION, P55
[5]   Role of insulin-like growth factor binding proteins in controlling IGF actions [J].
Clemmons, DR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 140 (1-2) :19-24
[6]   THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR - STRUCTURE, LIGAND-BINDING MECHANISM AND SIGNAL-TRANSDUCTION [J].
DEMEYTS, P ;
WALLACH, B ;
CHRISTOFFERSEN, CT ;
URSO, B ;
GRONSKOV, K ;
LATUS, LJ ;
YAKUSHIJI, F ;
ILONDO, MM ;
SHYMKO, RM .
HORMONE RESEARCH, 1994, 42 (4-5) :152-169
[7]   ROLE OF THE TIME FACTOR IN SIGNALING SPECIFICITY - APPLICATION TO MITOGENIC AND METABOLIC SIGNALING BY THE INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR TYROSINE KINASES [J].
DEMEYTS, P ;
CHRISTOFFERSEN, CT ;
URSO, B ;
WALLACH, B ;
GRONSKOV, K ;
YAKUSHIJI, F ;
SHYMKO, RM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10) :2-11
[8]   Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors [J].
DiCola, G ;
Cool, MH ;
Accili, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2538-2544
[9]   Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells [J].
Frasca, F ;
Pandini, C ;
Scalia, P ;
Sciacca, L ;
Mineo, R ;
Costantino, A ;
Goldfine, ID ;
Belfiore, A ;
Vigneri, R .
MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (05) :3278-3288
[10]   INSULIN IGF-1 HYBRID RECEPTORS - IMPLICATIONS FOR THE DOMINANT-NEGATIVE PHENOTYPE IN SYNDROMES OF INSULIN RESISTANCE [J].
FRATTALI, AL ;
TREADWAY, JL ;
PESSIN, JE .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 48 (01) :43-50